Alpha-fetoprotein peptides and uses thereof

Details Alpha-fetoprotein peptides and uses thereof Alpha-fetoprotein peptides and uses thereof

2007-02-26

2009-10-06

Landsman, Robert (Department: 1647)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S329000, C530S330000, C514S016700, C514S017400, C514S018700

Reexamination Certificate

active

07598342

ABSTRACT:
The invention relates to compounds that include peptide and peptidomimetics that inhibit estrogen receptor dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.

REFERENCES:
patent: 5674842 (1997-10-01), Mizejewski
patent: 5707963 (1998-01-01), Mizejewski
patent: 6306832 (2001-10-01), Pietras
patent: 6348567 (2002-02-01), Krystal et al.
patent: 6818741 (2004-11-01), Andersen et al.
patent: 7122522 (2006-10-01), Andersen et al.
patent: 7132400 (2006-11-01), Andersen et al.
patent: 2005/0271587 (2005-12-01), Andersen et al.
Jacobson et al., “Inhibition of Estrogen-dependent Breast Cancer Growth by a Reaction Product of α-Fetoprotein and Estradiol”,Cancer Researchvol. 50, 415-420, Jan. 15, 1990.
Bennett et al., “α-Fetoprotein Derived from a Human Hepatoma Prevents Growth of Estrogen-dependent Human Breast Cancer Xenografts”,Clinical Cancer Research, vol. 4, 287-2884, Nov. 1998.
Mesfin et al., “Development of a synthetic cyclized peptide derived from α-fetoprotein that prevents the growth of human breast cancer”,J. Peptide Res., 2001, vol.58, 246-256.
Defreest et al., “Synthetic peptide derived from α-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization”,J. Peptide Res., 2004, vol. 63, 409-419.
Bennett et al., “A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen”,PNAS, 2002; vol. 99, 2211-2215.
Eisele et al., “Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs”,J. Peptide Res., 2001, vol. 57, 29-38.
Eisele et al., “Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties”,J. Peptide Res., 2001, vol. 57, 539-546.
Aggarwal et al., “Synthesis and Screening of a Random Dimeric Peptide Library Using the One-Bead-One Dimer Combinatorial Approach”,Bioconjugate Chem., 2006, vol. 17, 335-340.
Aggarwal et al., “A Dimeric Peptide that Binds Selectively to Prostate-Specific Membrane Antigen and Inhibits its Enzymatic Activity”,Cancer Res 2006, vol. 66: (18): 9171-9177 Sep. 15, 2006.
O'Leary et al., “Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor”,The Journal of Biological Chemistry, vol. 278, No. 28, Jul. 11, 2003, 25738-25744.
Parikh et al., “Prevention ofN-Methyl-N-Nitrosourea-Induced Breast Cancer by α-Fetoprotein (AFP)—Derived Peptide, a Peptide Derived from the Active Site of AFP”,Clin Cancer Res, 2005; 11(23) Dec. 1, 2005; 8512-8520.
Mizejewski et al., “α-Fetoprotein growth inhibitory peptides: Potential leads for cancer therapeutics”,Mol Cancer Ther., 2003;2: 1243-1255.
Mesfin et al., “Alpha-fetoprotein-derived antiestrotrophic octapeptide”,Biochimica et Biophysica Acta1501 (2000) 33-43.

Affiliated with

Also associated with

Rating

Alpha-fetoprotein peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alpha-fetoprotein peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-fetoprotein peptides and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4091331